
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Devil's Claw Root contains iridoid glycosides including harpagoside and harpagide that inhibit inflammatory cytokines (IL-1β, IL-6, TNF-α) and block pro-inflammatory gene expression via the AP-1 pathway. The root demonstrates anti-inflammatory and analgesic effects primarily through modulation of leukotriene and thromboxane synthesis pathways.

Reported Benefits (Provisional)
Origin & History

Devil's Claw Root, derived from Harpagophytum procumbens, is native to the arid regions of Southern Africa, particularly Namibia, Botswana, and South Africa. This perennial plant is highly valued for its potent anti-inflammatory and analgesic properties, making it a significant botanical for joint health and pain management in functional nutrition.
Research Narrative (Provisional)
Numerous clinical trials and systematic reviews support Devil's Claw Root's efficacy in reducing pain and improving mobility in individuals with arthritis and back pain, primarily attributed to its anti-inflammatory iridoid glycosides. Further research continues to explore its full spectrum of benefits and mechanisms.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Iridoid glycosides (harpagoside, responsible for anti-inflammatory and analgesic effects), Phenolic compounds, Flavonoids (antioxidants), Phytosterols (support metabolic and hormonal balance). - Minerals: Calcium, Magnesium, Potassium (support bone, cardiovascular, and nerve health). - Fiber: Dietary fiber (promotes digestive health and gut microbiome balance).
Reported Mechanism (Provisional)
Harpagide inhibits inflammatory cytokines (IL-1β, IL-6, TNF-α) in macrophages and blocks pro-inflammatory gene expression via the AP-1 pathway. Harpagoside and its hydrolysates modulate leukotriene and thromboxane synthesis while activating the heme oxygenase-1/carbon monoxide system for pain relief. The iridoid glycosides also scavenge superoxide and peroxyl radicals in a dose-dependent manner, providing antioxidant protection.
Clinical Narrative (Provisional)
While multiple clinical investigations have demonstrated efficacy and safety for Devil's Claw Root, specific quantified outcomes from human trials are not well-documented in current literature. The anti-inflammatory and analgesic mechanisms are primarily supported by in vitro studies and animal models rather than large-scale human clinical trials. Research shows consistent anti-inflammatory activity across both Harpagophytum procumbens and H. zeyheri species. Further controlled human studies are needed to establish specific dosage recommendations and quantified therapeutic outcomes.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







